Low-dose IL-2 induces CD56 bright NK regulation of T cells via NKp44 and NKp46.
Autor: | McQuaid SL; Viral Immunology Laboratory, School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland.; Mason Technology Ltd, Dublin, Ireland., Loughran ST; Viral Immunology Laboratory, School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland.; Department of Applied Science, Dundalk Institute of Technology, Dundalk, Ireland., Power PA; Viral Immunology Laboratory, School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland.; Technological University Dublin, Dublin, Ireland., Maguire P; Viral Immunology Laboratory, School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland.; School of Biotechnology, Dublin City University, Dublin, Ireland., Szczygiel A; Viral Immunology Laboratory, School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland., Johnson PA; Viral Immunology Laboratory, School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical and experimental immunology [Clin Exp Immunol] 2020 Jun; Vol. 200 (3), pp. 228-241. Date of Electronic Publication: 2020 Feb 13. |
DOI: | 10.1111/cei.13422 |
Abstrakt: | Low-dose interleukin (IL)-2 has shown clinical benefits in patients with autoimmune and inflammatory diseases. Both regulatory T cells (T (© 2020 British Society for Immunology.) |
Databáze: | MEDLINE |
Externí odkaz: |